SNSE Stock: Sensei Biotherapeutics, Inc. Stock Price, Analysis & Insights
Get live snse stock price $10.67, comprehensive Sensei Biotherapeutics, Inc. stock analysis, charts, news, and expert forecast. Real-time snse stock data and investment insights.
Loading chart...
Company Overview
Sensei Biotherapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of immunotherapies with an initial focus on treatments for cancer. It develops proprietary ImmunoPhage platform, an immunotherapy approach that is designed to utilize bacteriophage to induce a focused and coordinated innate and adaptive immune response; and Tumor Microenvironment Activated Biologics, a platform designed to unleash the anti-tumor potential of T-cells, as well as human monoclonal antibodies that are selectively active in the tumor microenvironment and target immune checkpoints or other critical immune pathways. The company also develops SNS-101, a monoclonal antibody for the treatment of cancer; and SNS-401-NG, an ImmunoPhage vaccine targeting multiple tumor antigens. It has a collaboration with The University of Washington to research and develop Merkel cell carcinoma vaccine. The company was formerly known as Panacea Pharmaceuticals, Inc. Sensei Biotherapeutics, Inc. was incorporated in 1999 and is headquartered in Rockville, Maryland.
Company Information
- CEO
- Christopher W. Gerry
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 14
Contact Information
- Website
- https://www.senseibio.com
- Address
- 451 D Street
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Lower volatility stock (Beta: 0.31) may provide portfolio stability
Business Model & Strategy
Sensei Biotherapeutics, Inc. operates in the Biotechnology industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO Christopher W. Gerry, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Biotechnology model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
Sensei Biotherapeutics, Inc. competes in the Biotechnology within the broader Healthcare. With 13.5 million in market capitalization, the company is positioned as a emerging competitor in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the NASDAQ Global Market, Sensei Biotherapeutics, Inc. provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating Sensei Biotherapeutics, Inc. should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Sensei Biotherapeutics, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Sensei Biotherapeutics, Inc.
- ⚠Investors should consider how Sensei Biotherapeutics, Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
13.46M
P/E Ratio
-0.56
Beta
0.31
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 13.46M market capitalization
- Trading Volume: 97.03K shares traded today
- Price Range: 52-week range of $5.00 - $18.35
- Exchange: Listed on NASDAQ Global Market
Financial Metrics
Market Analysis for Sensei Biotherapeutics, Inc.
Sensei Biotherapeutics, Inc. (SNSE) operates in the Biotechnology industry within the Healthcare sector. With a current market capitalization of 13.46M, the company represents a significant player in its market. The stock is currently trading at $10.67 with a positivedaily change of 20.61%.
The company's 14 employee base and presence on the NASDAQ Global Marketexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -0.56, beta of 0.31, and 52-week price range from $5.00 to $18.35when evaluating investment opportunities.
Why Invest in Sensei Biotherapeutics, Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (NASDAQ Global Market)
- • Experienced leadership under Christopher W. Gerry
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.